CD86 regulates myeloma cell survival

17Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Although prognosis for patients with multiple myeloma has improved over the past decade, research toward discovery of new therapeutic avenues is important and could lead to a cure for this plasma cell malignancy. Here we show that blocking the CD28-CD86 pathway via silencing of either CD28 or CD86 leads to myeloma cell death. Inhibiting this pathway leads to downregulation of integrins and IRF4, a known myeloma survival factor. Our data also indicate that CD86, the canonical ligand in this pathway, has prosurvival activity that is dependent on its cytosolic domain. These findings indicate that targeting of this pathway is a promising therapeutic avenue for myeloma, because it leads to modulation of different processes important in cell viability.

Figures

References Powered by Scopus

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

3155Citations
N/AReaders
Get full text

Improved survival in multiple myeloma and the impact of novel therapies

1992Citations
N/AReaders
Get full text

Initial genome sequencing and analysis of multiple myeloma

1248Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Thrombospondin-1 Mediates Axon Regeneration in Retinal Ganglion Cells

95Citations
N/AReaders
Get full text

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

40Citations
N/AReaders
Get full text

Game of Bones: How Myeloma Manipulates Its Microenvironment

35Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gavile, C. M., Barwick, B. G., Newman, S., Neri, P., Nooka, A. K., Lonial, S., … Boise, L. H. (2017). CD86 regulates myeloma cell survival. Blood Advances, 1(25), 2307–2319. https://doi.org/10.1182/bloodadvances.2017011601

Readers over time

‘17‘18‘19‘20‘21‘22‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

69%

Researcher 4

31%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

46%

Medicine and Dentistry 4

31%

Agricultural and Biological Sciences 2

15%

Computer Science 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0